The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing anti-necrosis drugs for stroke.

Total Raised

$0.50 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Pharmaceutical

Investment History

  1. Equity

    Jun 2023

    $1M

Team

David Platt

Founder and CEO

Ola Soderquist

Finance and Administration

Michael Sheikh

Executive Vice President Business Development